CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
Cancer Research and Treatment. 2019;51(2):502-509.   Published online 2018 June 13    DOI: https://doi.org/10.4143/crt.2018.117

Excel Download

Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Cancer Research and Treatment. 2019;51(2):502-509   Crossref logo
Link1 Link2 Link3

Afatinib/erlotinib/gefitinib
Reactions Weekly. 2018;1705(1):15-15   Crossref logo
Link1 Link2 Link3

Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer
Lung Cancer. 2010;69(3):259-264   Crossref logo
Link1 Link2

Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer
Lung Cancer. 2016;99:1-3   Crossref logo
Link1 Link2

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer
Lung Cancer: Targets and Therapy. 2010;1   Crossref logo
Link1

Combination of afatinib with cetuximab in patients with EGFR-mutant non-small-cell lung cancer resistant to EGFR inhibitors
OncoTargets and Therapy. 2015;1137   Crossref logo
Link1

therascreen ® EGFR RGQ PCR Kit: A Companion Diagnostic for Afatinib and Gefitinib in Non-Small Cell Lung Cancer
Molecular Diagnosis & Therapy. 2016;20(2):191-198   Crossref logo
Link1 Link2 Link3

Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Lung Cancer. 2017;113:51-58   Crossref logo
Link1 Link2

Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer
Lung Cancer. 2007;58(3):414-417   Crossref logo
Link1 Link2

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations
Clinical Lung Cancer. 2016;17(5):412-418   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.